M3 USA Presents Landmark Research On Physicians’ Attitudes On Pharmaceutical Sales and Marketing at 2013 ePharma Summit

  M3 USA Presents Landmark Research On Physicians’ Attitudes On Pharmaceutical
  Sales and Marketing at 2013 ePharma Summit

Business Wire

WASHINGTON -- March 5, 2013

M3 USA (www.usa.m3.com) presented new data from its CompleteSpecialist series
of syndicated market research at the 12thannual ePharma Summit in New York
City. The detailed syndicated market research study explores how physician
specialists communicate with each of their practice audiences: patients,
peers, payers and pharmaceutical companies. The report also details and the
respective value and influence specialists ascribe to each type of channel. It
is the only study of its kind to date, and it breaks new ground in
understanding communication and promotion to the specialties that it covers.

PatientsMap, a large study developed by SSRI in partnership with M3,
demonstrates how physicians treat disease and interact with pharmaceutical
companies. PatientsMap extracts its data via a web-survey with over 6,000 US
physicians covering more than 380 diseases.

At the conference, Jack Bilson, VP of Product Development & Innovation, shared
key findings and analysis in his presentation, What you Know and What is True
About Physician Behavior, Communication and Preferences: An Analysis of
Pharmaceutical's Prognosis of Influence in the Medical World.

“In leveraging the valued insights from multiple sources within the M3 family
we have uncovered some new perspectives. This new data both reinforces and at
times challenges conventional wisdom about the communication behavior and
habits of physicians,” says Bilson.

The data that will be presented contains a breakdown of each included
specialist’s most respected pharmaceutical sales forces and other valuable
information on their digital and real world communication preferences of
physicians. As an example the most respected sales forces according to
Rheumatologists is as follows:

Most Respected Pharmaceutical Sales Force According to Rheumatologists from
PatientsMap
1. Abbott
2. Amgen
3. Pfizer
4. Genetech

About M3

M3 USA is a leader in the online healthcare professional community space. In
the US, MDLinx.com is the #1 specialty physician website and #2 overall
physician website. M3 is also the founding partner of Networks in Health, an
international alliance of online physician communities. In addition to
offering online promotional advertising mediums, M3 Global Research has the
largest global physician market research panel. This gives M3 an unprecedented
and unmatched reach across the planet in both eMarketing to physicians as well
all forms of market research for healthcare professionals.

The M3 Group operates in the US, Asia, and Europe with more than 1 million
physician members globally via its physician websites such as www.m3.com,
www.mdlinx.com, www.doctors.net.uk, and www.medigate.net. M3, Inc., a publicly
traded company on the Tokyo Stock Exchange (JP: 2413) provides services to
healthcare and life science industry to reach out to their audience. M3
services include medical education, ethical drug promotion, market research,
clinical development, job recruitment, and clinic appointment services. M3 has
offices in Tokyo, Washington D.C., Fort Washington, Oxford, London, and Seoul.

Contact:

M3 USA – MDLinx:
R. Gregory Jones, 908-310-3508
rgjones@mccpr.com
or
SSRI Social Survey Research Information:
Mina Asai, +81 3-3370-3244
miasai@ssri.com
 
Press spacebar to pause and continue. Press esc to stop.